Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition
William H D Hallett1, Erik Ames, Milad Motarjemi
1Department of Microbiology and Immunology, University of Nevada School of Medicine, University of Nevada, Reno, NV 89557, USA.
Abstract:
Bortezomib is a proteasome inhibitor that has direct antitumor effects. We and others have previously demonstrated that bortezomib could also sensitize tumor cells to killing via the death ligand, TRAIL. NK cells represent a potent antitumor effector cell. Therefore, we investigated whether bortezomib could sensitize tumor cells to NK cell-mediated killing. Preincubation of tumor cells with bortezomib had no effect on short-term NK cell killing or purified granule killing assays. Using a 24-h lysis assay, increases in tumor killing was only observed using perforin-deficient NK cells, and this increased killing was found to be dependent on both TRAIL and FasL, correlating with an increase in tumor Fas and DR5 expression. Long-term tumor outgrowth assays allowed for the detection of this increased tumor killing by activated NK cells following bortezomib treatment of the tumor. In a tumor purging assay, in which tumor:bone marrow cell mixtures were placed into lethally irradiated mice, only treatment of these mixtures with a combination of NK cells with bortezomib resulted in significant tumor-free survival of the recipients. These results demonstrate that bortezomib treatment can sensitize tumor cells to cellular effector pathways. These results suggest that the combination of proteasome inhibition with immune therapy may result in increased antitumor efficacy.
Insights
Bortezomib, a proteasome inhibitor, enhances tumor cell sensitivity to natural killer (NK) cell-mediated killing through TRAIL and FasL pathways. Combining proteasome inhibition with NK cell therapy may improve antitumor efficacy.
Area of Science:
- Immunology
- Cancer Biology
- Pharmacology
Background:
- Bortezomib is a proteasome inhibitor with direct antitumor effects.
- Bortezomib can sensitize tumor cells to TRAIL-mediated killing.
- Natural Killer (NK) cells are potent antitumor effector cells.
Purpose of the Study:
- To investigate if bortezomib sensitizes tumor cells to NK cell-mediated killing.
- To elucidate the mechanisms underlying bortezomib's effect on NK cell cytotoxicity.
- To evaluate the therapeutic potential of combining bortezomib with NK cell therapy.
Main Methods:
- Tumor cells were preincubated with bortezomib.
- Short-term and 24-hour NK cell killing assays were performed, including with perforin-deficient NK cells.
- Tumor outgrowth and tumor purging assays in mice were utilized.
- Expression of Fas and DR5 on tumor cells was analyzed.
Main Results:
- Bortezomib alone did not affect short-term NK cell killing.
- Increased tumor cell killing by perforin-deficient NK cells was observed, dependent on TRAIL and FasL.
- This correlated with increased Fas and DR5 expression on tumor cells.
- Combination therapy with bortezomib and NK cells led to significant tumor-free survival in mice.
Conclusions:
- Bortezomib sensitizes tumor cells to NK cell-mediated killing via TRAIL and FasL pathways.
- The combination of proteasome inhibition with NK cell therapy demonstrates increased antitumor efficacy.
- This suggests a promising therapeutic strategy for cancer treatment.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Tumor Immunotherapy
The Extrinsic Apoptotic Pathway

